scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1110351833 |
P356 | DOI | 10.1186/S13046-018-0978-X |
P932 | PMC publication ID | 6276256 |
P698 | PubMed publication ID | 30509303 |
P50 | author | Tarik Regad | Q55474203 |
Luigi Mele | Q85886047 | ||
P2093 | author name string | Angela Lombardi | |
Gianpaolo Papaccio | |||
Federica Papaccio | |||
Francesca Paino | |||
Marcella La Noce | |||
Vincenzo Desiderio | |||
Virginia Tirino | |||
P2860 | cites work | Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo. | Q39579276 |
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells | Q39932297 | ||
Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma | Q39978912 | ||
Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis | Q40213999 | ||
The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation | Q40690782 | ||
MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1. | Q41856145 | ||
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance | Q42014961 | ||
Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin | Q44668068 | ||
Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group | Q45842022 | ||
Expression profiles of osteosarcoma that can predict response to chemotherapy. | Q46706109 | ||
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development. | Q47104412 | ||
The fundamental role of epigenetic events in cancer | Q56421597 | ||
Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis | Q58610759 | ||
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 | ||
Massive genomic rearrangement acquired in a single catastrophic event during cancer development | Q24631164 | ||
Worms gang up on bacteria | Q27860588 | ||
A bivalent chromatin structure marks key developmental genes in embryonic stem cells | Q27860977 | ||
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia | Q28202279 | ||
The epigenomics of cancer | Q28289975 | ||
CD271+ osteosarcoma cells display stem-like properties | Q28539288 | ||
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription | Q29547568 | ||
Chromatin signatures of pluripotent cell lines | Q29614675 | ||
Epigenetics in cancer | Q29617139 | ||
The epigenetic progenitor origin of human cancer | Q29617486 | ||
Detection and characterization of CD133+ cancer stem cells in human solid tumours | Q33378520 | ||
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer | Q34188991 | ||
Osteosarcoma treatment - where do we stand? A state of the art review. | Q34392457 | ||
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization | Q34424921 | ||
Stem-like cells in bone sarcomas: implications for tumorigenesis | Q34769927 | ||
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 | Q35160462 | ||
Advances in sarcoma genomics and new therapeutic targets | Q35993346 | ||
Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways | Q36313178 | ||
Genetic and epigenetic regulators of pluripotency | Q36744480 | ||
Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells. | Q37088708 | ||
Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail | Q37114711 | ||
Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. | Q37235523 | ||
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors | Q37347838 | ||
Epigenetics in cancer stem cells | Q37618640 | ||
Human adipose stem cell differentiation is highly affected by cancer cells both in vitro and in vivo: implication for autologous fat grafting. | Q37744842 | ||
A meta-analysis of osteosarcoma outcomes in the modern medical era | Q38006949 | ||
Epigenetic alterations involved in cancer stem cell reprogramming | Q38058972 | ||
EMT transcription factors: implication in osteosarcoma | Q38131450 | ||
Bone microenvironment signals in osteosarcoma development | Q38454980 | ||
The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. | Q38543511 | ||
A common framework for EMT and collective cell migration. | Q39023896 | ||
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma | Q39246205 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 296 | |
P577 | publication date | 2018-12-03 | |
P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
P1476 | title | HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy | |
P478 | volume | 37 |